₹20/- For Intraday, F&O, Currencies & Commodities
Healthium Medtech Limited IPO
Healthium Medtech Limited IPO consists of fresh issue of equity shares of Rs 390 Cr. Plus, with an offer of sale of up to 39.10 million shares by current shareholders and promoters. Healthium Medtech has established itself as the largest medical device company and the second-largest one in the surgical consumables market in India.
Opening Date
To be announced
Closing Date
To be announced
Price Band
To be announced
Issue Size
To be announced
Face Value
To be announced
Market Lot
To be announced
Opening Date
To be announced
Closing Date
To be announced
Price Band
To be announced
Issue Size
To be announced
Face Value
To be announced
Market Lot
To be announced
Listing at NSE, BSE
Healthium Medtech Limited IPO Important Dates
| IPO Open Date | To be announced |
|---|---|
| IPO Close Date | To be announced |
| Allotment Date | To be announced |
| Initiation Of Refunds | To be announced |
| Credit Of Shares To Demat Account |
To be announced |
| IPO Listing Date | To be announced |
| UPI Mandate Expiry Date | To be announced |
About Healthium Medtech Limited
Healthium is a global Medtech company that focuses on surgical, post-surgical and chronic care. The company holds a vision to make precision Medtech products accessible to every patient globally. Healthium Medtech has a huge product base related to its focus areas with over 52,000 SKUs.
The brand has an amazing commercial presence and market access in India and the UK. They export products to over 80 countries including the US, UK, Germany and France (developed markets and South America, Asia and America (developing markets). Their comprehensive portfolio of quality products at captivating value makes the company stand out from the competition.
Healthium Medtech IPO Objectives
Here are a few quick reasons why Healthium Medtech going public:
- The fund will be used to create awareness and visibility of the company among the existing and potential customers.
- Investment of the fund into the brand’s subsidiaries Sironix, Clinisupplies and Quality Needles.
Why should you invest in the Healthium Medtech IPO?
- In India, Healthcare is amongst the fastest-growing markets in terms of revenue.
- As per Frost & Sullivan analysis, during the year 2021-2025, the Indian healthcare market is expected to grow at a sarge of 13.9%.
Financial Highlights
| Particulars | Fiscal ending March 31 | 2019 | 2020 | 2021 |
|---|---|---|---|
| Revenue from operations (₹ million) | 5,840.20 | 6,391.79 | 7,133.57 |
| Restated profit before tax (₹ million) | 243.04 | 578.81 | 1,130.33 |
| Restated profit for the year (₹ million) | 137.31 | 367.60 | 854.28 |
| Gross margin (%) | 65.26% | 65.89% | 62.33% |
| EBITDA (₹) | 544.27 | 955.74 | 1,539.27 |
| EBITDA margin (%) | 9.32% | 14.95% | 21.58% |
| ROE (%) | 3.57% | 10.98% | 21.57% |
| ROCE (%) | 6.45% | 16.08% | 22.98% |
| Cash conversion cycle (in days) | 219 | 171 | 139 |
| Net cash flow from operating activities (₹ million) | 514.38 | 589.24 | 1,221.29 |
| Net cash flows from/ (used in) operating activities / EBITDA (%) | 94.51% | 61.65% | 79.34% |
How to apply for Healthium Medtech IPO
Retail investors need to apply for the IPO using UPI.
UPI
- Link your bank account to a UPI ID.
- Register your UPI id with your Demat account.
- Subscribe for Healthium Medtech IPO and approve the payment on your UPI ID.
Demat Account
- If you’re a new investor, Open a DEMAT Account for free with Angel One and begin your investment journey.
Healthium Medtech IPO Noteworthy Highlights:
- The company is one of the largest direct sales forces among independent medical device Companies in India.
- The company has a strong footprint in Tier 3 and smaller cities of India. In FY21, 42.92% of the company’s revenue from India has come from tier 1 and tier 2 cities.
The Brand’s Pros & Cons:
| Pros | Cons |
|---|---|
| For the brand’s strong global reach, it is subjected to gain benefits from favorable industry dynamics in high growth market. | Any health pandemic, social unrest, and natural disasters can affect the business adversely. |
| The company’s R&D department has a proven track record of amazingly commercialising the products. | Any delay from the vendors can affect the business adversevely. |
| The brand's strong presence in India and several other countries (UK, US, Europe, etc.) has created a strong market reach for them. | Inflation in India can adversely affect the business. |
Competitive Analysis: Market Peers
Not available .
Healthium Medtech IPO FAQs
What is Healthium Medtech IPO?
When will the Healthium Medtech IPO allotment be available?
What will be the Healthium Medtech IPO lot size?
When will Healthium Medtech IPO open for subscription?
What minimum lot size can retail investors subscribe to?
When will Healthium Medtech list on exchanges?
How to check the allotment status of Healthium Medtech IPO?
What is the size of Healthium Medtech IPO?
How will I receive shares?
Is it necessary to approve a UPI mandate request immediately?
How to apply for this Healthium Medtech IPO via the Angel One App?
- Log in to your account
- Select Healthium Medtech from the Active IPO list
- Click 'Apply'
- Complete the bidding process and make payment through UPI
- Approve payment mandate on your UPI handle
What is the minimum order quantity for Healthium Medtech IPO?
Enjoy Zero Brokerage on
Stock Investments
Enjoy Lifetime Free Delivery Trade
Download the app now
Or Scan below QR Code
to download App
